NARI News and Press, Inari Medical Inc. From 05/01/24

2024-05-01 03:32:02 ET Inari Medical, Inc. (NARI) Q1 2024 Earnings Conference Call April 30, 2024, 16:30 PM ET Company Participants John Hsu - Vice President, Investor Relations Drew Hykes - Chief Executive Officer Mitch Hill - Chief Financial Officer Tom Tu ...

2024-04-30 17:08:43 ET More on Inari Medical Inari Medical: Buy On Growing TAM Inari Medical, Inc. (NARI) Q4 2023 Earnings Call Transcript Inari Medical, Inc. 2023 Q4 - Results - Earnings Call Presentation Piper Sandler cuts Inari to neutral; cites slowing gr...

2024-04-30 17:01:17 ET Gainers: Powell Industries ( POWL ) +19% . Root ( ROOT ) +16% . TransMedics Group ( TMDX ) +11% . Inari Medical ( NARI ) +7% . MannKind Corporation ( MNKD ) +5% . Losers: CVRx ( CVRX ) -16% ...

IRVINE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ende...

LPL Financial Holdings Inc. (LPLA) is expected to report $3.77 for Q1 2024 Banco Santander Brasil SA American Depositary Shares each representing one unit (BSBR) is expected to report $0.14 for Q1 2023 EnLink Midstream LLC representing Limited Partner Interests (ENLC) is expected to repor...

IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) --  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarte...

2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...

IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the publication of its 2023 Ethos and Susta...

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for potential violations of the federal securities l...

2024-04-09 16:49:42 ET Summary AngioDynamics has sold low-growth businesses, shifted to an outsourced manufacturing model, and refocused on cardiovascular and oncological care for potential growth. The recent approval of the AlphaVac F18 mechanical thrombectomy system for pulmonar...